While additional studies in larger Asian patient cohorts would be required to corroborate these findings and achieve statistical significance, they clearly demonstrate that a substantial portion of GC and CRC cancer patients present with or acquire high-level focal ERBB2 amplification. The gene discussed is ERBB2; the disease is gastric cancer.